Helping "vulnerable" children-and their parents-lead normal lives
June 1st 2006Vulnerable child syndrome distorts parents' perceptions of their child's health, disrupts the parent-child relationship, and can harm development and behavior in an otherwise healthy child. Here are steps you can take to recognize problems early and improve family interactions.
HPV vaccination may pose delivery concerns
April 29th 2006Pediatricians can expect problems meeting vaccination schedules forhuman papillomavirus (HPV) vaccine. Based on data from the 1996 to2002 Medical Expenditure Panel Survey, only 11% of adolescents haveprimary care visits on a schedule appropriate to HPV vaccination.
When a teen has a tot: A model of care for the adolescent parent and her child
April 1st 2006You can mitigate the health and educational risks faced by an adolescent parent and her child by providing a medical home for both. This "teen-tot" model of family-centered care provides a framework for success.
Answers to key questions about childhood leukemia--for the generalist
March 1st 2006What goes wrong with blood cells and genes of children who suffer this grim disease? And how has a high cure rate revealed late effects of treatment? Answers to these (and more) questions shape your ongoing basic care of patients at the onset of, during, and after their illness.
Progress in preventing cervical cancer and other HPV-related diseases, Part 1
March 1st 2006Expanding knowledge, new screening technologies, and effective vaccines have opened new horizons in, and put pediatricians at the forefront of, preventing cervical cancer and other diseases caused by human papillomavirus. Here's what we know now and what it means for your patients. First of two parts.
Trials show that two vaccines are effective against genital cancers and warts
January 13th 2006Two separate studies show that Merck & Co.'s and GlaxoSmithKline's human papillomavirus (HPV) vaccines appear highly effective in preventing cervical cancer, vulvar cancer, and genital warts.The recently completed trials involved Merck's Gardasil and GlaxoSmithKline's experimental vaccine. Earlier studies showed that Gardasil also protects against cervical intraepithelial neoplasia (CIN)-precancerous lesions that can develop into cervical cancer.